Trade PCRX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Pacira BioSciences, Inc. (PCRX) is trading at US$26.35, down 0.94% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$983.39M. Over the past 52 weeks, PCRX has traded between US$18.80 and US$27.66. On Syfe you can trade PCRX with $0 commission and add it to your watchlist.
| Previous close | US$26.60 |
|---|---|
| Market cap | US$983.39M |
| P/E ratio | 8.06 |
| 52-week range | US$18.80 – US$27.66 |
| Volume | 447.34K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pacira BioSciences, Inc.
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Brisbane, CA.
Year: 2011
RBC Adjusts Price Target on Pacira Biosciences to $25 From $24, Maintains Sector Perform Rating
Aug 5, 12:36 PM · MT Newswires
-- Earnings Flash (PCRX) Pacira BioSciences, Inc. Posts Q2 Adjusted EPS $0.73 per Share, vs. FactSet Est of $0.65
Aug 4, 8:15 PM · MT Newswires
-- Earnings Flash (PCRX) Pacira BioSciences, Inc. Reports Q2 Revenue $192.4M, vs. FactSet Est of $191.1M
Aug 4, 8:15 PM · MT Newswires
Pacira BioSciences Enrolls First Patient in Mid-stage Trial After Manufacturing Milestone
Jul 27, 12:46 PM · MT Newswires
Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday
Jul 1, 1:20 PM · MT Newswires
Pacira BioSciences, Inc. (PCRX) stock is trading at US$26.35, -0.94% from the previous close of US$26.60.
The market cap for Pacira BioSciences, Inc. (PCRX) stock is approximately US$983.39M.
The price-to-earnings ratio for Pacira BioSciences, Inc. (PCRX) is 8.06, based on the latest reported earnings.
The 52-week high for Pacira BioSciences, Inc. (PCRX) stock is US$27.66.
The 52-week low for Pacira BioSciences, Inc. (PCRX) stock is US$18.80.
Pacira BioSciences, Inc. (PCRX) does not currently pay a dividend.
Stay on top of PCRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
